Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.

Ann Surg Oncol · 2020

Where this comes from

Abstract

In the original article the authors' disclosures were incomplete.